Literature DB >> 23998348

Pacemaker implantation after transcatheter aortic valve implantation.

Gustavo Goldenberg1, Jairo Kusniec, Ehud Kadmon, Gregory Golovchiner, Ronit Zabarsky, Roman Nevzorov, Hana Vaknin, Abed Assali, Ran Kornowski, Moti Haim, Boris Strasberg.   

Abstract

Thirty- to 35% of patients after transcatheter aortic valve implantation undergo implantation of a permanent pacemaker (PPM) because of development of atrioventricular block (AVB) or development of a condition with high risk of progression to AVB. There are insufficient data regarding long-term follow-up on pacing dependency. From February 2009 to July 2011, 191 transcatheter aortic valve implantation procedures were performed at the Rabin Medical Center (125 CoreValve and 66 Edwards SAPIEN). Thirty-two patients (16.7%) received a PPM (30 with CoreValve and 2 with Edwards SAPIEN). Data from the pacemaker clinic follow-up was available in 27 patients. After a mean follow-up of 52 weeks (range, 22 to 103), only 8 (29%) of 27 patients were pacing dependent. The indication of PPM in these 8 patients was complete AVB. In conclusion, in our center, the rate of PPM implantation was 16%, which is lower than that reported in the published works. Only 29% of those patients implanted with PPM were pacemaker dependent. Further studies are necessary to define reliable predictors for long-term pacing.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23998348     DOI: 10.1016/j.amjcard.2013.07.022

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Clinical significance of conduction disturbances after aortic valve intervention: current evidence.

Authors:  Manuel Martinez-Selles; Peter Bramlage; Martin Thoenes; Gerhard Schymik
Journal:  Clin Res Cardiol       Date:  2014-07-04       Impact factor: 5.460

2.  Short-term pacemaker dependency after transcatheter aortic valve implantation.

Authors:  Christiana Schernthaner; Johannes Kraus; Franz Danmayr; Matthias Hammerer; Jens Schneider; Uta C Hoppe; Bernhard Strohmer
Journal:  Wien Klin Wochenschr       Date:  2016-01-08       Impact factor: 1.704

3.  Type of Atrial Fibrillation and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.

Authors:  Aviv A Shaul; Ran Kornowski; Tamir Bental; Hana Vaknin-Assa; Abid Assali; Gregory Golovchiner; Ehud Kadmon; Pablo Codner; Katia Orvin; Boris Strasberg; Alon Barsheshet
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-01-28       Impact factor: 1.468

4.  Pacemaker dependency after transcatheter aortic valve replacement compared to surgical aortic valve replacement.

Authors:  You Mi Hwang; Jun Kim; Gi Byoung Nam; Kee Joon Choi; Duk-Woo Park; Do-Yoon Kang; Seung-Jung Park; Seo Young Park
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

5.  One-year pacing dependency after pacemaker implantation in patients undergoing transcatheter aortic valve implantation: Systematic review and meta-analysis.

Authors:  Justine M Ravaux; Michele Di Mauro; Kevin Vernooy; Arnoud W Van't Hof; Leo Veenstra; Suzanne Kats; Jos G Maessen; Roberto Lorusso
Journal:  JTCVS Open       Date:  2021-02-12

6.  Transcatheter aortic valve implantation in very elderly patients: immediate results and medium term follow-up.

Authors:  Isaac Pascual; Antonio J Muñoz-García; Diego López-Otero; Pablo Avanzas; Manuel F Jimenez-Navarro; Belén Cid-Alvarez; Raquel Del Valle; Juan H Alonso-Briales; Raimundo Ocaranza-Sanchez; José M Hernández; Ramiro Trillo-Nouche; César Morís
Journal:  J Geriatr Cardiol       Date:  2015-07       Impact factor: 3.327

7.  Ten-year Survival and Its Associated Factors in the Patients Undergoing Pacemaker Implantation in Hospitals Affiliated to Shiraz University of Medical Sciences During 2002 - 2012.

Authors:  Abdolreza Rajaeefard; Mohammad Ghorbani; Mohammad Ali Babaee Baigi; Hamidreza Tabatabae
Journal:  Iran Red Crescent Med J       Date:  2015-11-14       Impact factor: 0.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.